ADVENZYMESBSEADVANCED ENZYME TECH LTD· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 22 Oct, 2026 · 17:42 IST

Advanced Enzymes buys back 58,326 shares at avg price of about 263 rupees on Oct 22, 2026

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.0%Reaction day
₹257.20
prior close
₹258.85
announcement price
After-mkt
timing
Nifty Microcap 250market-2.3%-0.7% vs market
Biotechnology peers, median of 5sector+0.7%-3.7% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 3.7 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.1
10m
-0.8
15m
-1.2
30m
-1.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.0-2.3-0.7+0.7-3.7
Next day
-1.2-1.9+0.7+2.3-3.5
2d
+1.3-0.2+1.6+4.4-3.1
3d
+1.8-0.2+2.0+4.1-2.3
4d
+3.4+0.5+2.9+5.4-2.0
5d
+1.1pendingpending+3.7-2.6
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advanced Enzyme Technologies bought back 58,326 equity shares on October 22, 2026, all executed through NSE via Emkay Global Financial Services. The average acquisition price was 263.36 rupees per share, excluding transaction costs. Cumulative shares bought back so far stand at 22,00,853. This daily report is filed under SEBI buyback regulations for the company's ongoing open market buyback program.

Likely market impact

Regular buyback updates show the company is actively returning capital to shareholders via the open market, which generally supports the share price.